Stocks › GMED

GLOBUS MEDICAL INC

GMED·NYSE·United States United States·USD
$66.89
-1.71 (-2.49%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
GMED
GLOBUS MEDICAL INC · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
GMEDS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of GMED by members of U.S. Congress · 36 on record · 3 in the last 12 months
All congressional trades →
PoliticianStockTypeFiledTraded
Gilbert Ray Cisneros, Jr.Gilbert Ray Cisneros, Jr.House · D · CA GMEDGLOBUS MEDICAL INC · Stock Purchase
$1,001 - $15,000
Oct 12, 2026 Sep 3, 2026 Filing ↗
Gilbert Ray Cisneros, Jr.Gilbert Ray Cisneros, Jr.House · D · CA GMEDGLOBUS MEDICAL INC · Stock Purchase
$15,001 - $50,000
Sep 10, 2026 Aug 19, 2026 Filing ↗
Gilbert Ray Cisneros, Jr.Gilbert Ray Cisneros, Jr.House · D · CA GMEDGLOBUS MEDICAL INC · Stock Purchase
$1,001 - $15,000
Apr 7, 2026 Mar 3, 2026 Filing ↗
Lisa C. McClainLisa C. McClainHouse · R · MI GMEDGLOBUS MEDICAL INC · Stock Sale
$1,001 - $15,000
Aug 13, 2025 Jun 24, 2025 Filing ↗
Lisa C. McClainLisa C. McClainHouse · R · MI GMEDGLOBUS MEDICAL INC · Stock Purchase
$1,001 - $15,000
Aug 13, 2025 Jun 17, 2025 Filing ↗
Lisa C. McClainLisa C. McClainHouse · R · MI GMEDGLOBUS MEDICAL INC · Stock Sale
$1,001 - $15,000
Aug 13, 2025 Jul 10, 2025 Filing ↗
Josh GottheimerJosh GottheimerHouse · D · NJ GMEDGLOBUS MEDICAL INC · Stock Sale
$1,001 - $15,000
May 14, 2025 Apr 9, 2025 Filing ↗
Josh GottheimerJosh GottheimerHouse · D · NJ GMEDGLOBUS MEDICAL INC · Stock Purchase
$1,001 - $15,000
May 19, 2023 Apr 3, 2023 Filing ↗
Daniel S. GoldmanDaniel S. GoldmanHouse · D · NY GMEDGLOBUS MEDICAL INC · Stock Sale
$15,001 - $50,000
Apr 17, 2023 Mar 6, 2023 Filing ↗
Josh GottheimerJosh GottheimerHouse · D · NJ GMEDGLOBUS MEDICAL INC · Stock Sale
$1,001 - $15,000
Mar 17, 2023 Feb 8, 2023 Filing ↗
Josh GottheimerJosh GottheimerHouse · D · NJ GMEDGLOBUS MEDICAL INC · Stock Sale
$1,001 - $15,000
Feb 17, 2023 Jan 11, 2023 Filing ↗
Ro KhannaRo KhannaHouse · D · CA GMEDGLOBUS MEDICAL INC · Common Stock Sale
$1,001 - $15,000
Sep 8, 2022 Aug 23, 2022 Filing ↗
Ro KhannaRo KhannaHouse · D · CA GMEDGLOBUS MEDICAL INC · Common Stock Sale
$1,001 - $15,000
Jul 7, 2022 — Filing ↗
Ro KhannaRo KhannaHouse · D · CA GMEDGLOBUS MEDICAL INC · Common Stock Purchase
$1,001 - $15,000
Jun 10, 2022 May 23, 2022 Filing ↗
Ro KhannaRo KhannaHouse · D · CA GMEDGLOBUS MEDICAL INC · Common Stock Purchase
$1,001 - $15,000
Jun 10, 2022 May 10, 2022 Filing ↗
Ro KhannaRo KhannaHouse · D · CA GMEDGLOBUS MEDICAL INC · Common Stock Sale
$1,001 - $15,000
Jan 7, 2022 Dec 15, 2021 Filing ↗
Gilbert Ray Cisneros, Jr.Gilbert Ray Cisneros, Jr.House · D · CA GMEDGLOBUS MEDICAL INC · Stock Sale
$1,001 - $15,000
Jun 16, 2020 Jun 1, 2020 Filing ↗
Josh GottheimerJosh GottheimerHouse · D · NJ GMEDGLOBUS MEDICAL INC · Stock Sale
$1,001 - $15,000
Jun 10, 2020 May 28, 2020 Filing ↗
Gilbert Ray Cisneros, Jr.Gilbert Ray Cisneros, Jr.House · D · CA GMEDGLOBUS MEDICAL INC · Stock Sale
$1,001 - $15,000
Apr 16, 2020 Mar 31, 2020 Filing ↗
Gilbert Ray Cisneros, Jr.Gilbert Ray Cisneros, Jr.House · D · CA GMEDGLOBUS MEDICAL INC · Stock Sale
$1,001 - $15,000
Mar 10, 2020 Feb 21, 2020 Filing ↗
Josh GottheimerJosh GottheimerHouse · D · NJ GMEDGLOBUS MEDICAL INC · Stock Purchase
$1,001 - $15,000
Sep 16, 2019 Jul 26, 2019 Filing ↗
Gilbert Ray Cisneros, Jr.Gilbert Ray Cisneros, Jr.House · D · CA GMEDGLOBUS MEDICAL INC · Stock Purchase
$1,001 - $15,000
Aug 19, 2019 Jul 30, 2019 Filing ↗
Lois FrankelLois FrankelHouse · D · FL GMEDGLOBUS MEDICAL INC · Stock Sale
$1,001 - $15,000
Jul 25, 2018 Jun 19, 2018 Filing ↗
Lois FrankelLois FrankelHouse · D · FL GMEDGLOBUS MEDICAL INC · Stock Sale
$1,001 - $15,000
Jul 25, 2018 Jun 18, 2018 Filing ↗
Lois FrankelLois FrankelHouse · D · FL GMEDGLOBUS MEDICAL INC · Stock Sale
$1,001 - $15,000
Apr 27, 2018 Apr 10, 2018 Filing ↗

Whale Activity

Position changes in GMED reported for 2026-09-30 by 681 institutional filers
Increased: 231New: 83Held: 88Decreased: 185Closed: 62No prior filing: 32
  • Increased231
  • New83
  • Held88
  • Decreased185
  • Closed62
  • No prior filing32
FilerSharesValueChange
BlackRock, Inc.10.9M$816.9Mincreased
Janus Henderson Group Ltd.8.6M$646.7M—
VANGUARD CAPITAL MANAGEMENT LLC5.1M$380.2Mdecreased
VANGUARD PORTFOLIO MANAGEMENT LLC4.9M$364.5Mdecreased
STATE STREET CORP3.7M$278.5Mincreased
Boston Partners3.4M$255.9Mincreased
JPMORGAN CHASE & CO3.2M$239.5Mincreased
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC3.2M$239.4Mdecreased
DIMENSIONAL FUND ADVISORS LP3.0M$225.3Mincreased
Swedbank AB2.9M$215.8Mincreased
ALLIANCEBERNSTEIN L.P.2.8M$207.8Mincreased
Invesco Ltd.2.6M$194.8Mdecreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by GMED insiders, by quarter · Form 4
-100.0K-50.0K050.0K100.0K2025 Q1: -21.7K2025 Q12025 Q2: 02025 Q22025 Q3: -10.0K2025 Q32025 Q4: -90.0K2025 Q42026 Q1: -35.6K2026 Q12026 Q2: -25.0K2026 Q22026 Q3: -55.0K2026 Q32026 Q4: -46.7K2026 Q4

Recent Insider Transactions

411 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
TOBIN JAMES RDirector · Director Sale −4,004 $75.68 $303K Nov 10, 2026 Form 4 ↗
TOBIN JAMES RDirector · Director Sale −37.7K $75.10 $2.8M Nov 10, 2026 Form 4 ↗
RHOADS ANN DDirector · Director Sale −5,000 $85.00 $425K Nov 4, 2026 Form 4 ↗
TOBIN JAMES RDirector Sale −30.0K $74.58 $2.2M Sep 15, 2026 Form 4 ↗
TOBIN JAMES RDirector Option exercise +15.0K $63.68 $955K Sep 15, 2026 Form 4 ↗
TOBIN JAMES RDirector Option exercise +15.0K $53.75 $806K Sep 15, 2026 Form 4 ↗
ZARRILLI STEPHEN TDirector Sale −25.0K $87.04 $2.2M Aug 18, 2026 Form 4 ↗
ZARRILLI STEPHEN TDirector Option exercise +25.0K $53.27 $1.3M Aug 18, 2026 Form 4 ↗
Davidar David DDirector Gift −2,500 $0.00 $0 Jul 27, 2026 Form 4 ↗
Davidar David DDirector Sale −25.0K $80.76 $2.0M Jun 5, 2026 Form 4 ↗
Davidar David DDirector Option exercise +25.0K $26.27 $657K Jun 5, 2026 Form 4 ↗
RHOADS ANN DDirector Option exercise +25.0K $26.27 $657K Jun 4, 2026 Form 4 ↗
Huller KellyEVP, GC, Corporate Secretary Sale −20.0K $94.50 $1.9M Feb 25, 2026 Form 4 ↗
Huller KellyEVP, GC, Corporate Secretary Option exercise +20.0K $43.58 $872K Feb 25, 2026 Form 4 ↗
Huller KellyEVP, GC, Corporate Secretary Sale −10.0K $87.67 $877K Feb 12, 2026 Form 4 ↗
Huller KellyEVP, GC, Corporate Secretary Option exercise +10.0K $45.64 $456K Feb 12, 2026 Form 4 ↗
Kline KyleSenior Vice President, CFO Sale −3,594 $101.10 $363K Jan 8, 2026 Form 4 ↗
Kline KyleSenior Vice President, CFO Option exercise +3,594 $51.87 $186K Jan 8, 2026 Form 4 ↗
Norwalk Leslie VDirector Sale −2,000 $101.10 $202K Jan 8, 2026 Form 4 ↗
Norwalk Leslie VDirector Sale −4,000 $88.85 $355K Dec 12, 2025 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding GMED · SEC Form N-PORT
FundSharesValue% of fundAs of
iShares Core S&P Mid-Cap ETF
iShares Trust
3.9M$306.4M0.25%Jun 30, 2026
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
3.6M$284.1M0.01%Jun 30, 2026
VANGUARD SMALL-CAP INDEX FUND
VANGUARD INDEX FUNDS
2.6M$205.3M0.11%Jun 30, 2026
Janus Henderson Enterprise Fund
Janus Investment Fund
2.2M$174.4M0.78%Jun 30, 2026
VANGUARD SMALL-CAP GROWTH INDEX FUND
VANGUARD INDEX FUNDS
1.5M$118.2M0.25%Jun 30, 2026
JPMorgan Mid Cap Value Fund
J.P. Morgan Fleming Mutual Fund Group, Inc.
1.5M$116.6M1.04%Jun 30, 2026
VANGUARD EXTENDED MARKET INDEX FUND
VANGUARD INDEX FUNDS
1.3M$102.7M0.11%Jun 30, 2026
Allspring Special Mid Cap Value Fund
ALLSPRING FUNDS TRUST
1.2M$97.5M0.72%Jun 30, 2026
Janus Henderson Triton Fund
Janus Investment Fund
1.1M$87.8M1.48%Jun 30, 2026
Disciplined Value Mid Cap Fund
John Hancock Funds III
1.0M$81.4M0.35%Jun 30, 2026

Mutual funds and ETFs whose N-PORT filings list GMED's shares (CUSIP 379577208), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Vanguard Capital ManagementSCHEDULE 13G/A · passive (13G) · 6.0M shares4.4%
    Oct 30, 2026 · ↗
  • BlackRock, Inc.SCHEDULE 13G/A · passive (13G) · 10.7M shares8.0%
    Oct 27, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming globus medical as client
$0$0$1$1$12023202420252026
  • BALLARD SPAHR LLPGLOBUS MEDICAL, INC. · 2026 Q3—
    Filing ↗
  • BALLARD SPAHR LLPGLOBUS MEDICAL, INC. · 2026 Q3—
    Filing ↗
  • BALLARD SPAHR LLPGLOBUS MEDICAL, INC. · 2026 Q2—
    Filing ↗
  • BALLARD SPAHR LLPGLOBUS MEDICAL, INC. · 2026 Q1—
    Filing ↗
  • BALLARD SPAHR LLPGLOBUS MEDICAL, INC. · 2025 Q4—
    Filing ↗

Government Contracts

Federal awards to globus medical · USAspending
$248KAwarded · 11 contracts on record
  • Department of Veterans AffairsPROSTHETICS - SURGICAL IMPLANT$91K
    Nov 16, 2026 · ↗
  • Department of DefensePRECISION LENGTHENING LEG SYSTEM$64K
    Feb 20, 2026 · ↗
  • Department of Defense4573064408!REVERE$2K
    Jul 28, 2026 · ↗
  • Department of Defense4572580890!SPCR SPNL 12X19MM FORTIFY 12MM NS LF$11K
    Jul 22, 2026 · ↗
  • Department of Defense4570297354!SABLE$13K
    Dec 15, 2025 · ↗
  • Department of Defense4572495289!SPCR SPNL 30X10X6MM SABLE 8D STRL LF$9K
    Jul 21, 2026 · ↗
  • Department of Defense4572452841!INSTAFILL$1K
    Jul 15, 2026 · ↗
  • Department of Defense4572525148!INDEPENDENCE MIS SPACER 26 X 34MM 8, 13M$17K
    May 28, 2026 · ↗

U.S. Patents

Recent USPTO applications naming GLOBUS MEDICAL INC

No USPTO patent applications found for GLOBUS MEDICAL INC.

Annual Financials

From GMED's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$2.94B$2.52B$1.57B$1.02B$958.1M
Operating income$479.8M$166.0M$133.1M$228.0M$172.0M
Net income$537.9M$103.0M$122.9M$190.2M$149.2M
Diluted EPS$3.92$0.75$1.07$1.85$1.44
Operating cash flow$753.4M$520.6M$243.5M$178.5M$276.3M
Cash and equivalents$526.2M$784.4Mn/an/an/a
Total assets$5.30B$5.25B$5.09B$2.08B$1.96B
Total liabilities$729.5M$1.07B$1.09B$229.8M$215.9M
Shareholders' equity$4.57B$4.18B$4.00B$1.85B$1.74B

As GLOBUS MEDICAL INC tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 24, 2026 ↗

Stock Splits

Every split and reverse split in the price history

No stock splits in GMED's price history.

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 2.02, 8.01, 9.01Results of operations · Other eventsNov 5, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsAug 6, 2026
    EDGAR ↗
  • 8-K · Items 5.02, 5.07, 9.01Officer / director change · Shareholder voteJun 4, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsMay 7, 2026
    EDGAR ↗

About GLOBUS MEDICAL INC

From SEC EDGAR company records
Industry (SIC 3841)Surgical & Medical Instruments & Apparatus
SectorHealthcare
HeadquartersAUDUBON, PA
IncorporatedDE